CBF Cobra Bio-Man.

 

TIDMCBF 
 
RNS Number : 8161E 
Seymour Pierce Ltd 
30 December 2009 
 
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 
WITH RECOGNISED INTERMEDIARY STATUS 
DEALING IN A CLIENT-SERVING CAPACITY 
(Rule 38.5(a) of the Takeover Code) 
 
 
1.    KEY INFORMATION 
 
 
+------------------------------------+------------------------------------------------------+ 
| Name of exempt principal trader    | Seymour Pierce Limited                               | 
+------------------------------------+------------------------------------------------------+ 
| Company dealt in                   | Cobra Bio-Manufacturing plc                          | 
+------------------------------------+------------------------------------------------------+ 
| Class of relevant security to      | Ordinary 1p Shares                                   | 
| which the dealings being disclosed |                                                      | 
| relate (Note 1)                    |                                                      | 
+------------------------------------+------------------------------------------------------+ 
| Date of dealing                    | 29.12.09                                             | 
+------------------------------------+------------------------------------------------------+ 
 
 
 
 
2.    DEALINGS (Note 2) 
 
 
(a)Purchases and sales 
 
 
+------------------------------+-----------------------------+-------------------------------+ 
| Total number of securities   | Highest price paid (Note 3) | Lowest price paid (Note 3)    | 
| purchased                    |                             |                               | 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
| 60,000                       | 0.02126 GBP                 | 0.02126 GBP                   | 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
 
 
 
 
+------------------------------+-----------------------------+-------------------------------+ 
| Total number of securities   | Highest price received      | Lowest price received (Note   | 
| sold                         | (Note 3)                    | 3)                            | 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
 
 
(b)    Derivatives transactions (other than options) 
 
 
+-----------------+--------------------+----------------------------+-------------------------+ 
| Product name,   | Long/short (Note   | Number of securities (Note | Price per unit (Note 3) | 
| e.g. CFD        | 4)                 | 5)                         |                         | 
+-----------------+--------------------+----------------------------+-------------------------+ 
|                 |                    |                            |                         | 
+-----------------+--------------------+----------------------------+-------------------------+ 
 
 
 
 
(c)    Options transactions in respect of existing securities 
(i)    Writing, selling, purchasing or varying 
 
 
+-----------------+--------------+-----------------+----------+------------+---------+---------------+ 
| Product name,   | Writing,     | Number of       | Exercise | Type, e.g. | Expiry  | Option money  | 
| e.g. call       | selling,     | securities to   | price    | American,  | date    | paid/received | 
| option          | purchasing,  | which the       |          | European   |         | per unit      | 
|                 | varying etc. | option relates  |          | etc.       |         | (Note 3)      | 
|                 |              | (Note 5)        |          |            |         |               | 
+-----------------+--------------+-----------------+----------+------------+---------+---------------+ 
|                 |              |                 |          |            |         |               | 
+-----------------+--------------+-----------------+----------+------------+---------+---------------+ 
 
 
(ii)    Exercising 
 
 
+------------------------------+-----------------------------+-------------------------------+ 
| Product name, e.g. call      | Number of securities        | Exercise price per unit (Note | 
| option                       |                             | 3)                            | 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
|                              |                             |                               | 
+------------------------------+-----------------------------+-------------------------------+ 
 
 
 
 
3.    OTHER INFORMATION 
 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
 
 
 
+------------------------------------------------------------------------------------------+ 
| Full details of any agreement, arrangement or understanding between the person           | 
| disclosing and any other person relating to the voting rights of any relevant securities | 
| under any option referred to on this form or relating to the voting rights or future     | 
| acquisition or disposal of any relevant securities to which any derivative referred to   | 
| on this form is referenced. If none, this should be stated.                              | 
+------------------------------------------------------------------------------------------+ 
|                                                                                          | 
+------------------------------------------------------------------------------------------+ 
 
 
 
 
 
 
+---------------------------------------------------+---------------------------------------+ 
| Date of disclosure                                | 30.12.09                              | 
+---------------------------------------------------+---------------------------------------+ 
| Contact name                                      | Lynette Patterson                     | 
+---------------------------------------------------+---------------------------------------+ 
| Telephone number                                  | 020 7107 8033                         | 
+---------------------------------------------------+---------------------------------------+ 
| Name of offeree/offeror with which connected      | Cobra Bio-Manufacturing plc           | 
+---------------------------------------------------+---------------------------------------+ 
| Nature of connection (Note 6)                     | Nomad & Broker                        | 
+---------------------------------------------------+---------------------------------------+ 
 
 
 
 
Notes 
 
 
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 EMMCKKKBKBDDDBN 
 

Cobra Bio-manufacturing (LSE:CBF)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025

Cobra Bio-manufacturing (LSE:CBF)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025